| Primary |
| Pneumonia |
35.6% |
| Drug Use For Unknown Indication |
26.4% |
| Sepsis |
8.6% |
| Atypical Mycobacterial Infection |
4.9% |
| Pneumonia Aspiration |
3.7% |
| Pseudomonas Infection |
2.5% |
| Pneumonia Cytomegaloviral |
2.2% |
| Gastric Ulcer Haemorrhage |
2.0% |
| Infection |
2.0% |
| Muscle Abscess |
2.0% |
| Peritonitis |
1.5% |
| Pneumonia Chlamydial |
1.2% |
| Urinary Tract Infection |
1.2% |
| Acute Respiratory Distress Syndrome |
1.0% |
| Diabetes Mellitus |
1.0% |
| Hypertension |
1.0% |
| Psoas Abscess |
1.0% |
| Cholangitis Acute |
0.7% |
| Chronic Obstructive Pulmonary Disease |
0.7% |
| Dialysis |
0.7% |
|
| Hypoglycaemia |
18.1% |
| Renal Failure Acute |
7.4% |
| Renal Impairment |
7.4% |
| Toxic Epidermal Necrolysis |
6.4% |
| Convulsion |
5.3% |
| Pruritus |
5.3% |
| Rash |
5.3% |
| Liver Disorder |
4.3% |
| Platelet Count Decreased |
4.3% |
| Shock |
4.3% |
| Agranulocytosis |
3.2% |
| Aplastic Anaemia |
3.2% |
| Cardiac Failure |
3.2% |
| Cerebral Infarction |
3.2% |
| Death |
3.2% |
| Granulocytopenia |
3.2% |
| Haematuria |
3.2% |
| Interstitial Lung Disease |
3.2% |
| Lung Disorder |
3.2% |
| Melaena |
3.2% |
|
| Secondary |
| Pneumonia |
24.2% |
| Drug Use For Unknown Indication |
22.9% |
| Gastric Ulcer Haemorrhage |
10.5% |
| Hypertension |
9.2% |
| Acute Respiratory Distress Syndrome |
5.2% |
| Pneumonia Mycoplasmal |
4.6% |
| Back Pain |
2.6% |
| Emphysema |
2.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.6% |
| Cholangitis Acute |
2.0% |
| Pneumonia Aspiration |
2.0% |
| Atrial Fibrillation |
1.3% |
| Cerebrovascular Accident Prophylaxis |
1.3% |
| Dementia |
1.3% |
| Diverticulitis |
1.3% |
| Hepatic Neoplasm Malignant |
1.3% |
| Infection Prophylaxis |
1.3% |
| Insomnia |
1.3% |
| Postoperative Wound Infection |
1.3% |
| Prophylaxis |
1.3% |
|
| Hypoglycaemia |
20.0% |
| Toxic Epidermal Necrolysis |
17.5% |
| Blood Alkaline Phosphatase Increased |
10.0% |
| Cerebral Infarction |
7.5% |
| Pyrexia |
7.5% |
| Renal Failure Acute |
7.5% |
| Hepatitis Acute |
5.0% |
| Interstitial Lung Disease |
5.0% |
| Pneumonia |
5.0% |
| Rash |
5.0% |
| Shock |
5.0% |
| Renal Impairment |
2.5% |
| Skin Plaque |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
81.3% |
| Hepatic Neoplasm Malignant |
9.4% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
6.3% |
| Renal Cell Carcinoma Stage Iv |
3.1% |
|
| Pyrexia |
50.0% |
| Upper Gastrointestinal Haemorrhage |
25.0% |
| Wound Dehiscence |
25.0% |
|
| Interacting |
| Muscle Abscess |
25.8% |
| Pseudomonas Infection |
25.8% |
| Psoas Abscess |
12.9% |
| Abscess |
6.5% |
| Convulsion |
6.5% |
| Diabetes Mellitus |
6.5% |
| Pneumonia Legionella |
6.5% |
| Staphylococcal Infection |
6.5% |
| Myocardial Infarction |
3.2% |
|
| Granulocytopenia |
42.9% |
| Convulsion |
28.6% |
| Hypoglycaemia |
28.6% |
|
